SA
TRAX logo
First Tracks Biotherapeutics Inc(TRAX)
Closing price · checked 4:14 PM ETAbout this dataData status
$41.64▼-2.82 (-6.34%)
Extended:$41.64+0.00 (+0.00%)· 4:14 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

First Tracks Biotherapeutics Inc (TRAX)

Operating Cash Flow (Statement)

-$120.17M

TTM · Period ending: · USD

TRAX logo

TRAX Operating Cash Flow (Statement)

Latest reported-$120.17M
TRAX Cash from Operations (-$93.00M → -$120.17M)
Powered by
High-resolution chart · PNG

What is operating cash flow (statement)?

Net cash provided by operating activities.

TRAX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

First Tracks Biotherapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)Change
-142,926,000—
-125,806,000—
-93,004,000—

Frequently asked questions: TRAX operating cash flow (statement)

What is First Tracks Biotherapeutics Inc (TRAX)'s current operating cash flow (statement)?

First Tracks Biotherapeutics Inc (TRAX)'s latest reported operating cash flow (statement) (TTM) is -$120.17M as of Sep 30, 2026. Net cash provided by operating activities.

How much historical operating cash flow (statement) data is available for TRAX?

Stock Alarm Pro provides 3 dated annual fiscal periods observations for First Tracks Biotherapeutics Inc (TRAX)'s operating cash flow (statement), allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare TRAX's operating cash flow (statement) to peers or set an alert?

You can open TRAX's operating cash flow (statement) in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on TRAX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.